AWA
JAZZ icon

Aaron Wealth Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Aaron Wealth Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$581K Sell
2,411
-113
-4% -$24.8K 0.03% 381
2026
Q1 		$477K Sell
2,524
-455
-15% -$79.5K 0.03% 400
2025
Q4 		$506K Buy
+2,979
New +$457K 0.03% 434
2025
Q2 		– Sell
-2,341
Closed -$291K – 502
2025
Q1 		$291K Sell
2,341
-101
-4% -$13.2K 0.03% 334
2024
Q4 		$301K Buy
+2,442
New +$288K 0.03% 320

Other funds holding JAZZ

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BCM
BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Aaron Wealth Advisors's JAZZ Position: Q2 2026 in Review

Aaron Wealth Advisors reduced its Jazz Pharmaceuticals (JAZZ) stake by 4.5% in Q2 2026, selling an estimated $24.8K and leaving 2,411 shares worth $581K. The position accounts for 0.03% of the portfolio, ranked #381.

Aaron Wealth Advisors first reported a position in JAZZ in Q4 2024 and has held it in 5 quarters since. 87 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Aaron Wealth Advisors held 2,411 shares of Jazz Pharmaceuticals worth $581K as of Q2 2026.
  • Aaron Wealth Advisors sold 113 Jazz Pharmaceuticals shares in Q2 2026, an estimated $24.8K.
  • Jazz Pharmaceuticals made up 0.03% of Aaron Wealth Advisors's portfolio in Q2 2026, its #381 holding.
  • Aaron Wealth Advisors first reported a position in Jazz Pharmaceuticals in Q4 2024 and has held it in 5 quarters since.
  • 87 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Aaron Wealth Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.